<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Monday, Feb. 11, 2008</title>
	<atom:link href="http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Mon, 23 Nov 2009 21:25:39 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; PharmatrophiX gets $300K for Alzheimer’s disease prevention drugs</title>
		<link>http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/comment-page-1/#comment-785682</link>
		<dc:creator>VentureBeat &#187; PharmatrophiX gets $300K for Alzheimer’s disease prevention drugs</dc:creator>
		<pubDate>Mon, 11 Feb 2008 19:23:46 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/#comment-785682</guid>
		<description>[...] our story about this San Francisco biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this San Francisco biotech in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Bacchus Vascular gets $15M for clot-busting device</title>
		<link>http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/comment-page-1/#comment-785486</link>
		<dc:creator>VentureBeat &#187; Bacchus Vascular gets $15M for clot-busting device</dc:creator>
		<pubDate>Mon, 11 Feb 2008 17:40:27 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/#comment-785486</guid>
		<description>[...] our story on this Santa Clara, Calif., medical-device maker in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story on this Santa Clara, Calif., medical-device maker in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; PolyRemedy, developer of robotic wound care, takes in $25M</title>
		<link>http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/comment-page-1/#comment-785444</link>
		<dc:creator>VentureBeat &#187; PolyRemedy, developer of robotic wound care, takes in $25M</dc:creator>
		<pubDate>Mon, 11 Feb 2008 17:17:19 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/02/11/life-sciences-briefing-monday-feb-11-2008/#comment-785444</guid>
		<description>[...] our story about this Mountain View, Calif., startup in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</description>
		<content:encoded><![CDATA[<p>[...] our story about this Mountain View, Calif., startup in today&#8217;s daily briefing at VentureBeat Life Sciences.  Tagged N/A         VentureBeat [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
